Genetic Variants, Helicobacter Pylori Infection, and Oesophageal Adenocarcinoma Risk
Author Information
Author(s): Früh M, Zhou W, Zhai R, Su L, Heist R S, Wain J C, Nishioka N S, Lynch T J, Shepherd F A, Christiani D C, Liu G
Primary Institution: Princess Margaret Hospital, University of Toronto
Hypothesis
Genetic variants associated with greater inflammatory gene and higher MMP expression are associated with a greater extent of chronic atrophic gastritis and greater protection against the risk of EA.
Conclusion
The study found that Helicobacter pylori infection is protective against oesophageal adenocarcinoma risk, particularly in individuals with the wild-type MMP2 genotype.
Supporting Evidence
- Helicobacter pylori infection was found to be protective against oesophageal adenocarcinoma.
- The MMP2 −1306 polymorphism showed a strong protective effect against EA in individuals with the wild-type genotype.
- Other MMP polymorphisms also indicated decreased EA risk in wild-type carriers.
Takeaway
This study suggests that having a certain type of gene can help protect people from a specific type of cancer, especially if they have a common stomach infection.
Methodology
The study analyzed serum samples from 100 cases of oesophageal adenocarcinoma and 101 matched healthy controls, focusing on genetic polymorphisms and Helicobacter pylori infection status.
Potential Biases
Potential biases due to the reliance on self-reported data and the limitations of serologic testing.
Limitations
The sample size was modest, and the serologic evaluation of prior HP infection may be imperfect.
Participant Demographics
Participants were primarily Caucasian, with a similar age and gender distribution between cases and controls.
Statistical Information
P-Value
0.29
Confidence Interval
0.1–0.7
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website